Insights From DPHARM: Reimagining The Future Of Connected Clinical Trials

By Carolina Canape Business Development Lead Digital Health

As decentralized clinical trials continue to gain momentum, the industry is moving beyond discussions of possibility and toward practical strategies for improving efficiency, data quality, and patient engagement. Digital technologies are playing an increasingly important role in clinical research, helping sponsors overcome persistent challenges related to remote data collection, protocol adherence, and operational complexity. Insights shared at DPHARM highlight how connected devices, real-time monitoring, and integrated digital ecosystems are reshaping the future of clinical development.

A key focus is the growing need for reliable, high-quality data generated outside traditional clinical settings. Advances in connected health technologies are enabling more accurate tracking of treatment adherence, reducing manual data entry, and providing greater visibility into patient experiences between site visits. These capabilities can support more patient-centric study designs while helping research teams make faster, more informed decisions.

Explore the opportunities and challenges shaping the next generation of connected clinical trials, including the evolving role of decentralized models, digital integration, and data-driven approaches that aim to improve outcomes for both sponsors and patients.